Carna Biosciences, Inc. Credit Rating

BOSTON (AI Credit Rating Terminal) Thu Jul 30 2020 23:49:03 GMT+0000 (Coordinated Universal Time) AI Credit Ratings today took the rating actions below:

Rating Action Overview


We downgraded Carna Biosciences, Inc. because has further large bullet maturities next year and its reliance on alternative financing. We use econometric methods for period (n+7) simulate with Modified (Smoothed) Moving Average Sign Test. Reference code is: 1133. Beta DRL value REG 44 Rational Demand Factor LD 4502.463. For companies that engage in reverse factoring--where accounts payable (AP) days are extended beyond the term customary for the industry and supply chain--we assess the likelihood and potential impact on liquidity of these arrangements ceasing to exist. In such a scenario, a company could be subject to material working capital outflows if AP days with its suppliers revert back to industry norms. Accordingly, we exclude these arrangements from sources of liquidity. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the credit rating risk map for Carna Biosciences, Inc. as below:

Credit Ratings for Carna Biosciences, Inc. as of 30 Jul 2020


Credit Rating Short-Term Long-Term Senior
AI Rating Class*Ba2B2
Semantic Signals7535
Financial Signals6451
Risk Signals8360
Substantial Risks8554
Speculative Signals3974

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com